Correlation Between Anebulo Pharmaceuticals and OncoCyte Corp
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and OncoCyte Corp, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and OncoCyte Corp.
Diversification Opportunities for Anebulo Pharmaceuticals and OncoCyte Corp
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Anebulo and OncoCyte is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and OncoCyte Corp go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and OncoCyte Corp
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 2.51 times more return on investment than OncoCyte Corp. However, Anebulo Pharmaceuticals is 2.51 times more volatile than OncoCyte Corp. It trades about 0.01 of its potential returns per unit of risk. OncoCyte Corp is currently generating about -0.01 per unit of risk. If you would invest 210.00 in Anebulo Pharmaceuticals on September 12, 2024 and sell it today you would lose (53.00) from holding Anebulo Pharmaceuticals or give up 25.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. OncoCyte Corp
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| OncoCyte Corp |
Anebulo Pharmaceuticals and OncoCyte Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and OncoCyte Corp
The main advantage of trading using opposite Anebulo Pharmaceuticals and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| OncoCyte Corp vs. Burning Rock Biotech | OncoCyte Corp vs. Neuronetics | OncoCyte Corp vs. DarioHealth Corp | OncoCyte Corp vs. Sera Prognostics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |